A case report of male breast cancer in a very young patient: What is changing?

详细信息    查看全文

• 作者：Marcelo Madeira (1) (2)
  André Mattar (1) (3)
  Rodrigo José Barata Passos (1)
  Caroline Dornelles Mora (3)
  Henrique Beralde Vilar Luiz Mamede (2)
  Viviane Hatsumi Kishino (2)
  Thomas Zurga Markus Torres (2)
  Fernandes Rodrigues Andressa de Sá (2)
  Roberto Euzébio dos Santos (2) (3)
  Luiz Henrique Gebrim (1) (3)
  
• 刊名：World Journal of Surgical Oncology
• 出版年：2011
• 出版时间：December 2011
• 年：2011
• 卷：9
• 期：1
• 全文大小：868KB
• 参考文献：1. Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. / Lancet 2006, 367: 595-04. CrossRef
  2. Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U: Male breast cancer: a special therapeutic problem. Anything new? (Review). / Int J Oncol 2004, 24: 663-70.
  3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. / CA Cancer J Clin 2009, 59: 225-49. CrossRef
  4. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN: Breast carcinoma in men: a population-based study. / Cancer 2004, 101: 51-7. CrossRef
  5. Anderson WF, Althuis MD, Brinton LA, Devesa SS: Is male breast cancer similar or different than female breast cancer? / Breast Cancer Res Treat 2004, 83: 77-6. CrossRef
  6. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ: Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. / Ann Epidemiol 2005, 15: 773-80. CrossRef
  7. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. / J Natl Cancer Inst 1998, 90: 1371-388. CrossRef
  8. Czene K, Bergqvist J, Hall P, Bergh J: How to treat male breast cancer. / Breast 2007, 16 (Suppl 2) : S147-54.
  9. Ahmad R, Lewis S, Maharaj D: A male patient from the West Indies with invasive ductal carcinoma in the right breast: A case report and literature review. / Gend Med 2010, 7: 179-83. CrossRef
  10. Giordano SH: A review of the diagnosis and management of male breast cancer. / Oncologist 2005, 10: 471-79. CrossRef
  11. Cutuli B: Strategies in treating male breast cancer. / Expert Opin Pharmacother 2007, 8: 193-02. CrossRef
  12. Nielsen US, Jakobsen EH: [Breast cancer in 32-year-old male]. / Ugeskr Laeger 2008, 170: 1663.
  13. Chang HL, Kish JB, Smith BL, Goldstein AM: A 16-year-old male with gynecomastia and ductal carcinoma in situ. / Pediatr Surg Int 2008, 24: 1251-253. CrossRef
  14. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. / J Clin Oncol 2002, 20: 1480-490. CrossRef
  15. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. / Am J Hum Genet 1997, 60: 313-19.
  16. Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A: BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. / Cancer Res 1998, 58: 1367-371.
  17. Misra SP, Misra V, Dwivedi M: Cancer of the breast in a male cirrhotic: is there an association between the two? / Am J Gastroenterol 1996, 91: 380-82.
  18. Ganly I, Taylor EW: Breast cancer in a trans-sexual man receiving hormone replacement therapy. / Br J Surg 1995, 82: 341. CrossRef
  19. Colombo-Benkmann M, Stern J, Herfarth C: On the neglected entity of unilateral gynecomastia. / Ann Plast Surg 2006, 56: 346. CrossRef
  20. Gomez-Raposo C, Zambrana Tevar F, Sereno Moyano M, Lopez Gomez M, Casado E: Male breast cancer. / Cancer Treat Rev 2010.
  21. Auvinen A, Curtis RE, Ron E: Risk of subsequent cancer following breast cancer in men. / J Natl Cancer Inst 2002, 94: 1330-332.
  22. Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B: Contralateral breast cancer: annual incidence and risk parameters. / J Clin Oncol 1995, 13: 1578-583.
  23. Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS: A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). / Cancer Causes Control 1996, 7: 382-90. CrossRef
  24. Bruce DM, Heys SD, Payne S, Miller ID, Eremin O: Male breast cancer: clinico-pathological features, immunocytochemical characteristics and prognosis. / Eur J Surg Oncol 1996, 22: 42-6. CrossRef
  25. Chantra PK, So GJ, Wollman JS, Bassett LW: Mammography of the male breast. / AJR Am J Roentgenol 1995, 164: 853-58.
  26. Volpe CM, Raffetto JD, Collure DW, Hoover EL, Doerr RJ: Unilateral male breast masses: cancer risk and their evaluation and management. / Am Surg 1999, 65: 250-53.
  27. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN: Adjuvant systemic therapy for male breast carcinoma. / Cancer 2005, 104: 2359-364. CrossRef
  28. Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y: Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. / Cancer 2005, 104: 521-24. CrossRef
  
• 作者单位：Marcelo Madeira (1) (2)
  André Mattar (1) (3)
  Rodrigo José Barata Passos (1)
  Caroline Dornelles Mora (3)
  Henrique Beralde Vilar Luiz Mamede (2)
  Viviane Hatsumi Kishino (2)
  Thomas Zurga Markus Torres (2)
  Fernandes Rodrigues Andressa de Sá (2)
  Roberto Euzébio dos Santos (2) (3)
  Luiz Henrique Gebrim (1) (3)
  
  1. Senology Discipline, S?o Paulo Federal University, S?o Paulo, Brazil
  2. Senology Discipline, UNINOVE University, S?o Paulo, Brazil
  3. Centro de Referência da Saúde da Mulher (CRSM), S?o Paulo, Brazil
  

文摘

Male breast cancer accounts for 1% of all breast cancer cases, and men tend to be diagnosed at an older age than women (mean age is about 67 years). Several risk factors have been identified, such as genetic and hormonal abnormalities. The present study reported the case of a 25-year-old man who was diagnosed with an advanced invasive ductal carcinoma; however, he did not have any important risk factors. Even though more data is emerging about this disease, more efforts to understand risk factors, treatment options and survival benefits are needed. In this case, we discussed the risk factors as well as the impaired fertility associated with breast cancer therapies.